Memory Pharmaceuticals to Announce Third Quarter 2005 Results on Tuesday, November 8, 2005
MONTVALE, N.J., November 1, 2005 -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) announced today that it will report its third quarter 2005 financial results on Tuesday, November 8, 2005, before the U.S. financial markets open. Management will provide a Company update and discuss the third quarter results during a conference call on Tuesday, November 8, 2005, at 11:00 a.m. ET. Tony Scullion, Executive Chairman, Jim Sulat, President and Chief Executive Officer, and Dr. David Lowe, Chief Scientific Officer, will host the conference call.
An audio replay of the conference call will be available from 1:00 p.m. EDT on Tuesday, November 8, 2005, until Tuesday, November 15, 2005. To access the replay, please dial 888-286-8010 (U.S.) or 617-801-6888 (international) and enter pass code number 89813462. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders such as Alzheimer's disease, schizophrenia, depression, vascular dementia, mild cognitive impairment, Parkinson's disease and memory impairments associated with aging. For additional information, please visit our website at http://www.memorypharma.com.